Profile

Gregory W. Evans, M.A.Wake Forest School of Medicine

Gregory W. Evans, M.A.

Section Head,
Associate Professor,

Contact Information

Academic: 336-716-6016 | Department: 336-716-2011

Email: gevans@wakehealth.edu

Education & Training

  • B.A., University of Missouri-Columbia, 1977
  • M.A., University of Missouri-Columbia, 1979
Gregory W. Evans, M.A.

Gregory W. Evans, M.A.

Section Head, Biostatistical Sciences
Associate Professor, Biostatistical Sciences
Neurology

Research Interests

Tunica Intima; Carotid Artery, Common; Carotid Artery Diseases; Fluorobenzenes; Pyrimidines
More »

Contact Information

Academic: 336-716-6016 | Department: 336-716-2011

Email: gevans@wakehealth.edu

Recent Publications

Carotid intima-media thickness measurements: relations with atherosclerosis, risk of cardiovascular disease and application in randomized controlled trials. Bots ML, Evans GW, Tegeler CH, Meijer R.. Chin Med J (Engl). 2016;129(2):215-226.

Patterns and correlates of baseline thiazide-type diuretic prescription in the systolic blood pressure intervention trial. Chang TI, Evans G, Cheung AK, Cushman WC, Diamond MJ, Dwyer JP, Huan Y, Kitzman D, Kostis JB, Oparil S, Rastogi A, Roumie CL, Sahay R, Stafford RS, Taylor AA, Wright JT Jr, Chertow GM.. Hypertension. 2016;67(3):550-555.

Antihypertensive medications and sexual function in women: baseline data from the SBP intervention trial (SPRINT). Thomas HN, Evans GW, Berlowitz DR, Chertow GM, Conroy MB, Foy CG, Glasser SP, Lewis CE, Riley WT, Russell L, Williams O, Hess R.. J Hypertens. 2016;34(6):1224-1231.

Common carotid intima-media thickness relates to cardiovascular events in adults aged less than 45 years. Eikendal AL, Groenewegen KA, Anderson TJ, Britton AR, Engstrom G, Evans GW, de Graaf J, Grobbee DE, Hedblad B, Holewijn S, Ikeda A, Kitagawa K, Kitamura A, Lonn EM, Lorenz MW, Mathiesen EB, Nijpels G, Dekker JM, Okazaki S,.. Hypertension. 2015;65(4):707-713.

Systolic blood pressure control among individuals with type 2 diabetes: a comparative effectiveness analysis of three interventions. Espeland MA, Probstfield J, Hire D, Redmon JB, Evans GW, Coday M, Lewis CE, Johnson KC, Wilmoth S, Bahnson J, Dulin MF, Green JB, Knowler WC, Kitabchi A, Murillo AL, Osei K, Rehman SU, Cushman WC, Ambrosius WT, Greven CM, Lovato JF, Perdue LH, et al.. Am J Hypertens. 2015;28(8):995-1009.

Intensive BP control, falls, and fractures: response to Jolobe (MS #17620) [reply to letter]. Margolis KL, Evans GW, Schwartz AV, Fleg J.. J Gen Intern Med. 2015;30(5):547.

Race/ethnic differences in the associations of the Framingham risk factors with carotid IMT and cardiovascular events. Gijsberts CM, Groenewegen KA, Hoefer IE, Eijkemans MJ, Asselbergs FW, Anderson TJ, Britton AR, Dekker JM, Engstrom G, Evans GW, de Graaf J, Grobbee DE, Hedblad B, Holewijn S, Ikeda A, Kitagawa K, Kitamura A, de Kleijn DP, Lonn EM,.. PLoS One. 2015;10(7):e0132321.

Effect of intensive blood pressure lowering on incident atrial fibrillation and p-wave indices in the ACCORD blood pressure trial. Chen LY, Bigger JT, Hickey KT, Chen H, Lopez-Jimenez C, Banerji MA, Evans G, Fleg JL, Papademetriou V, Thomas A, Woo V, Seaquist ER, Soliman EZ.. Am J Hypertens. 2015;():.

Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with diabetes mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure trial. Soliman EZ, Byington RP, Bigger JT, Evans G, Okin PM, Goff DC Jr, Chen H.. Hypertension. 2015;66(6):1123-1129.

Long-term cardiovascular effects of 4.9 years of intensive blood pressure control in type 2 diabetes mellitus: the Action to Control Cardiovascular Risk in Diabetes Follow-On Blood Pressure study [abstract]. Cushman WC, Evans GW, Cutler JA.. Circulation. 2015;132(23):2281.

Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. Ardoin SP, Schanberg LE, Sandborg CI, Barnhart HX, Evans GW, Yow E, Mieszkalski KL, Ilowite NT, Eberhard A, Imundo LF, Kimura Y, Levy D, von Scheven E, Silverman E, Bowyer SL, Punaro L, Singer NG, Sherry DD, McCurdy DK, Klein-Gitelman M,.. Ann Rheum Dis. 2014;73(3):557-566.

Carotid intima-media thickness is associated with incident heart failure among middle-aged whites and backs: the Atherosclerosis Risk in Communities study. Effoe VS, Rodriguez CJ, Wagenknecht LE, Evans GW, Chang PP, Mirabelli MC, Bertoni AG.. J Am Heart Assoc. 2014;3(3):e000797.

Common carotid intima-media thickness measurements do not improve cardiovascular risk prediction in individuals with elevated blood pressure: the USE-IMT collaboration. Bots ML, Groenewegen KA, Anderson TJ, Britton AR, Dekker JM, Engstrom G, Evans GW, de Graaf J, Grobbee DE, Hedblad B, Hofman A, Holewijn S, Ikeda A, Kavousi M, Kitagawa K, Kitamura A, Ikram MA, Lonn EM, Lorenz MW, Mathiesen EB,.. Hypertension. 2014;63(6):1173-1181.

Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial. Margolis KL, O'Connor PJ, Morgan TM, Buse JB, Cohen RM, Cushman WC, Cutler JA, Evans GW, Gerstein HC, Grimm RH Jr, Lipkin EW, Narayan KM, Riddle MC Jr, Sood A, Goff DC Jr.. Diabetes Care. 2014;37(6):1721-1728.

The relation between antihypertensive medication and sexual function in women: baseline data from the Sprint Study [abstract]. Thomas HN, Evans GW, Berlowitz D, Bonds DE, Chertow GM, Conroy MB, Foy C, Glasser S, Lewis CE, Cora E, Riley WT, Russell L, Williams O, Hess R.. J Gen Intern Med. 2014;29(Suppl 1):S231.

Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD trial. Margolis KL, Palermo L, Vittinghoff E, Evans GW, Atkinson HH, Hamilton BP, Josse RG, O'Connor PJ, Simmons DL, Tiktin M, Schwartz AV.. J Gen Intern Med. 2014;29(12):1599-1606.

Common carotid intima-media thickness does not add to Framingham risk score in individuals with diabetes mellitus: the USE-IMT initiative. den Ruijter HM, Peters SA, Groenewegen KA, Anderson TJ, Britton AR, Dekker JM, Engstrom G, Eijkemans MJ, Evans GW, de Graaf J, Grobbee DE, Hedblad B, Hofman A, Holewijn S, Ikeda A, Kavousi M, Kitagawa K, Kitamura A,.. Diabetologia. 2013;56(7):1494-1502.

Bilateral common carotid artery ultrasound for prediction of incident strokes using intima-media thickness and external diameter: an observational study. Eigenbrodt ML, Evans GW, Rose KM, Bursac Z, Tracy RE, Mehta JL, Couper DJ.. Cardiovasc Ultrasound. 2013;11():22.

Transcranial Doppler velocities in a large, healthy population. Tegeler CH, Crutchfield K, Katsnelson M, Kim J, Tang R, Passmore Griffin L, Rundek T, Evans G.. J Neuroimaging. 2013;23(3):466-472.

Extensive or restricted ultrasound protocols to measure carotid intima-media thickness: analysis of completeness rates and impact on observed rates of change over time. Peters SAE, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR III, O'Leary DH, Evans GW, Raichlen JS, Bots ML.. J Am Soc Echocardiogr. 2012;25(1):91-100.

Use of atorvastatin in systemic lupus erythematosus in children and adolescents. Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW, Mieszkalski KL, Ilowite NT, Eberhard A, Imundo LF, Kimura Y, von Scheven E, Silverman E, Bowyer SL, Punaro M, Singer NG, Sherry DD, McCurdy D, Klein-Gitelman M, Wallace C, Silver R,.. Arthritis Rheum. 2012;64(1):285-296.

Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparison. Peters SAE, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR III, O'Leary DH, Evans GW, Raichlen JS, Lind L, Bots ML.. J Intern Med. 2012;271(3):247-256.

Biologically implausible carotid intima-media thickness measurement values: effects on rate of change over time. Peters SAE, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR III, O'Leary DH, Evans GW, Raichlen JS, Bots ML.. Curr Med Res Opin. 2012;28(6):891-899.

Sample size requirements in trials using repeated measurements and the impact of trial design. Peters SAE, Palmer MK, den Ruijter HM, Grobbee DE, Crouse JR III, O'Leary DH, Evans GW, Raichlen JS, Bots ML.. Curr Med Res Opin. 2012;28(5):681-688.

Multiple imputation of missing repeated outcome measurements did not add to linear mixed-effects models. Peters SAE, Bots ML, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR III, O'Leary DH, Evans GW, Raichlen JS, Moons KG, Koffijberg H.. J Clin Epidemiol. 2012;65(6):686-695.

Intensive blood pressure treatment does not improve cardiovascular outcomes in centrally obese hypertensive individuals with diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial. Barzilay JI, Howard AG, Evans GW, Fleg JL, Cohen RM, Booth GL, Kimel AR, Pedley CF, Cushman WC.. Diabetes Care. 2012;35(7):1401-1405.

Increased age, high body mass index and low HDL-C levels are related to an echolucent carotid intima-media: the METEOR study. Peters SAE, Lind L, Palmer MK, Grobbee DE, Crouse JR III, O'Leary DH, Evans GW, Raichlen J, Bots ML, den Ruijter HM.. J Intern Med. 2012;272(3):257-266.

A clinically relevant benefit of statins in young patients with [reply to letter]. Ardoin SP, Evans G, Sandborg C, Barnhart HX, Schanberg LE.. Arthritis Rheum. 2012;64(8):2805-2806.

Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. Den Ruijter HM, Peters SAE, Anderson TJ, Britton AR, Dekker JM, Eijkemans MJ, Engstrom G, Evans GW, de Graaf J, Grobbee DE, Hedblad B, Hofman A, Holewijn S, Ikeda A, Kavousi M, Kitagawa K, Kitamura A, Koffijberg H, Lonn EM, Lorenz MW,.. JAMA. 2012;308(8):796-803.

Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial. Lind L, Peters SAE, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR III, O'Leary DH, Evans GW, Raichlen JS, Bots ML.. J Am Soc Echocardiogr. 2012;25(10):1120-1127.

Diabetes control among Hispanics in the Action to Control Cardiovascular Risk in Diabetes trial. Getaneh A, Light LS, Brillon DJ, Calles Escandon J, Felicetta J, Evans GW, Lopez-Jimenez CR, Cuddihy R, Bigger JT.. J Gen Intern Med. 2012;27(11):1499-1505.

Effect of number of ultrasound examinations on the assessment of carotid intima-media thickness changes over time: the example of the METEOR study. Peters SAE, Palmer MK, Grobbee DE, Crouse JR III, Evans GW, Raichlen JS, Bots ML.. J Hypertens. 2011;29(6):1145-1154.

Algorithms to measure carotid intima-media thickness in trials: a comparison of reproducibility, rate of progression and treatment effect. Dogan S, Plantinga Y, Crouse JR III, Evans GW, Raichlen JS, O'Leary DH, Palmer MK, Grobbee DE, Bots ML.. J Hypertens. 2011;29(11):2181-2193.

The use of plaque score measurements to assess changes in atherosclerotic plaque burden induced by lipid-lowering therapy over time: the METEOR study. Peters SAE, Dogan S, Meijer R, Palmer MK, Grobbee DE, Crouse JR III, O'Leary DH, Evans GW, Raichlen JS, Bots ML.. J Atheroscler Thromb. 2011;18(9):784-795.

Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study. Crouse JR III, Bots ML, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Raichlen JS.. Eur J Cardiovasc Prev Rehabil. 2010;17(2):223-229.

Effects of intensive blood-pressure control in type 2 diabetes mellitus. Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, et al.. N Engl J Med. 2010;362(17):1575-1585.

Completeness of carotid intima media thickness measurements depends on body composition: the RADIANCE 1 and 2 trials. Dogan S, Duivenvoorden R, Grobbee DE, Kastelein JJP, Shear CL, Evans GW, Visseren FL, Bots ML.. J Atheroscler Thromb. 2010;17(5):526-535.

Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Pop-Busui R, Evans GW, Gerstein HC, Fonseca V, Fleg JL, Hoogwerf BJ, Genuth S, Grimm RH, Corson MA, Prineas R.. Diabetes Care. 2010;33(7):1578-1584.

Brief stress-reduction training in an academic health center [letter]. LaRose A, Danhauer SC, Feldman J, Evans GW, Kemper KJ.. J Altern Complement Med. 2010;16(9):935-936.

Ultrasound protocols to measure carotid intima-media thickness in trials; comparison of reproducibility, rate of progression, and effect of intervention in subjects with familial hypercholesterolemia and subjects with mixed dyslipidemia. Dogan S, Duivenvoorden R, Grobbee DE, Kastelein JJP, Shear CL, Evans GW, Visseren FL, Bots ML.. Ann Med. 2010;42(6):447-464.

Striking increases in carotid artery wall thickness in healthy subjects. Meijer R, Stork S, Evans GW, Grobbee DE, Bots ML.. Cerebrovasc Dis. 2010;30(5):448-455.

Linkage analysis of carotid intima-media thickness in the Jackson Heart Study [abstract]. Buxbaum SG, Ekunwe L, Fox ER, Evans G, Sarpong DF.. Genet Epidemiol. 2010;34(8):959.

Ultrasound protocols to measure carotid intima-media thickness: a post-hoc analysis of the OPAL study. Dogan S, Plantinga Y, Evans GW, Meijer R, Grobbee DE, Bots ML.. Curr Med Res Opin. 2009;25(1):109-122.

The relation of C-reactive protein to carotid intima-media thickness in African Americans: the Jackson Heart Study [abstract]. Nagarajarao HS, Taylor HA, Lee JH, Benjamin EJ, Agrawal K, Evans G, Fox ER.. Circulation. 2009;119(10):e315.

Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study. Bots ML, Palmer MK, Dogan S, Plantinga Y, Raichlen JS, Evans GW, O'Leary DH, Grobbee DE, Crouse JR III.. J Intern Med. 2009;265(6):698-707.

Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW, Mieszkalski KL, Ilowite NT, Eberhard A, Levy DM, et al.. Arthritis Rheum. 2009;60(5):1496-1507.

Intensive glucose control and macrovascular outcomes in type 2 diabetes. Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, Evans GW, Gerstein HC, Holman RR, Moritz TE, et al.. Diabetologia. 2009;52(11):2288-2298.

C-reactive protein lowering with rosuvastatin in the METEOR study [abstract]. Bots M, Palmer M, Grobbee D, Crouse J, O'Leary D, Evans G, Raichlen J.. Atheroscler Suppl. 2009;10(2):Abstr P952.

Assessment of carotid plaque progression with ultrasound in a low-risk population [abstract]. Dogan S, Meijer R, Grobee D, Crouse J, O'Leary D, Evans G, Raichlen J, Palmer M, Bots M.. Atheroscler Suppl. 2009;10(2):Abstr P953.

Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the Rating Atherosclerotic Disease Change by Imaging with a New CETP Inhibitor (RADIANCE) Trials. Vergeer M, Bots ML, van Leuven SI, Basart DC, Sijbrands EJ, Evans GW, Grobbee DE, Visseren FL, Stalenhoef AF, Stroes ES, et al.. Circulation. 2008;118(24):2515-2522.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Biostatistical Sciences

Gregory W. Evans, M.A.

Gregory W. Evans, M.A.

Section Head, Biostatistical Sciences
Associate Professor, Biostatistical Sciences
Neurology

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.